Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia

This publication has 14 references indexed in Scilit:

• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
  Blood, 2003
• A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex–mismatched bone marrow transplantation
  Blood, 2002
• Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
  Transplantation and Cellular Therapy, 2001
• Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions
  Bone Marrow Transplantation, 2001
• Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia
  Blood, 2001
• Bone Marrow Transplantation for Sickle Cell Disease
  Journal of Pediatric Hematology/Oncology, 1999
• Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
  Journal of Clinical Oncology, 1998
• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplant
  Cancer Genetics and Cytogenetics, 1992
• Bone Marrow Transplantation for Sickle Cell Disease
  New England Journal of Medicine, 1991